NASDAQ: ALDX       Aldeyra Therapeu
Last Price Today's Change   Day's Range   Trading Volume
6.48   +0.17 (2.69%)  6.39 - 6.96  271,812


Avg Volume (4 weeks):569,210
4 Weeks Range:6.21 - 8.70
4 Weeks Price Volatility (%):
52 Weeks Range:1.48 - 8.70
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Aldeyra Therapeutics Inc is a biotechnology company operating in the US. It focuses on the development of new products for inflammation, inborn errors of metabolism, and other diseases that are thought to be related to endogenously generated toxic and pro-inflammatory chemical species known as aldehydes. The company is developing ADX-102 as well as other novel product candidates, including ADX-103 and ADX-104, which are designed specifically to sequester aldehydes for the treatment Noninfectious Anterior Uveitis, Allergic Conjunctivitis, Dry Eye Syndrome and other. The company operates through the single segment being, the Identification, and development of a treatment for diseases related to high levels of aldehydes.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1858  4042  356  3140 

Top 10 Active Counters
 LK 1.38+1.38 
 BLRX 2.895+1.415 
 NIO 30.63-1.36 
 AAPL 109.05-6.27 
 OAS 0.155-0.014 
 SQQQ 25.30+1.94 
 TWTR 41.85-10.58 
 HTZ 1.780.00 
 GE 7.40+0.03 
 AMTD 39.97-0.85